← Leaderboards
David Timothy Hoang
Thomas Jefferson University
$132,227
Attributed
$132,227
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $47.7K · FY2013–15$50K$37.5K$25K$12.5K$0
'13
'14
'15
Funding mix
By agency
NIH$132,227 · 1
By mechanism
F31$132,227 · 1
Top collaborators
No co-investigators on record.
Most similar at Thomas Jefferson University
Same institution · by research overlap
- Marja T Nevalainen$4,195,518
- Kay Huebner$4,927,479
- Theodore J Price$21,784,254
- Jeffrey L Benovic$31,875,251
- Randy Schrecengost$644,861
Others in their field
Top investigators on “Adjuvant Therapy”
- Lawrence Corey · Fred Hutchinson Cancer Center$265,384,749
- Norman Wolmark · Nsabp Foundation, Inc.$252,082,455
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$105,968,129
- David Heimbrook · Leidos Biomedical Research, Inc.$59,661,099
- Dan H. Barouch · Fred Hutchinson Cancer Center$58,263,037
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$58,263,037
Research focus
Adjuvant TherapyAndrogen ReceptorAndrogensAnimalsAnticancer ResearchAntisense OligonucleotidesApoptosisApoptoticAutomobile DrivingBaseBasic ScienceBehaviorBiochemicalBiologicalBiological ModelsBiomedical ResearchCancer PatientCancer Stem CellChromatin ImmunoprecipitationDeprivationDistantDoctor Of PhilosophyGenesAccounting
Grant awards (3)
Stat5 acts independently of androgen receptor to drive advanced prostate cancer$41,212
F31 · FY2015 · CA · contact PI
Stat5 acts independently of androgen receptor to drive advanced prostate cancer$47,676
F31 · FY2014 · CA · contact PI
Stat5 acts independently of androgen receptor to drive advanced prostate cancer$43,339
F31 · FY2013 · CA · contact PI